GlassScriptPhysician profile
Janna K Chun
NPI 1306482492
$2,926.63
in general payments reported to CMS, 2019-2025
23 companies · $137 in 2025
The $137 reported for 2025 was less than what a typical Family provider received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $222 · 2022: $351 · 2023: $1,730 · 2024: $486 · 2025: $137.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,353.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,353.13 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $815.81 | 2021-2025 | Farxiga, Breztri |
| Bayer Healthcare Pharmaceuticals INC. | $323.42 | 2022-2024 | |
| Amgen INC. | $298.60 | 2023 | Evenity, Repatha |
| Abbvie INC. | $246.08 | 2023-2025 | |
| Glaxosmithkline, LLC. | $200.41 | 2023-2024 | Arexvy, Trelegy Ellipta, Shingrix |
| Novo Nordisk INC | $191.30 | 2021-2024 | Rybelsus, Ozempic, Wegovy |
| Lilly USA, LLC | $173.86 | 2021-2024 | Jardiance, Mounjaro, Zepbound |
| Dexcom, INC. | $132.29 | 2023 | Dexcom G7 Gss (161) |
| Boehringer Ingelheim Pharmaceuticals, INC. | $81.49 | 2021-2024 | Jardiance |
| Idorsia Pharmaceuticals US INC | $63.39 | 2023-2024 | Quviviq |
| Exact Sciences Corporation | $61.76 | 2023-2024 | Cologuard Collection Kit |
| Janssen Pharmaceuticals, INC | $55.27 | 2023-2024 | Spravato |
| Antares Pharma, INC. | $53.87 | 2024 | Xyosted |
| Amarin Pharma, INC. | $42.53 | 2021 | |
| Azurity Pharmaceuticals, INC. | $27.50 | 2023 | Edarbyclor |
Show all 23 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Axsome Therapeutics, INC. | $25.17 | 2024 | Auvelity |
| Corium, LLC | $24.38 | 2023 | Azstarys |
| Alk-Abello, INC | $23.65 | 2023 | Grastek, Ragwitek, Odactra |
| Philips North America LLC | $21.55 | 2024 | (Ck7) Extended Holter |
| Inari Medical, INC. | $20.96 | 2023 | Flowtriever Catheter, S, Ct Thrombectomy System Kit |
| Eisai INC. | $16.36 | 2021 | |
| Merck Sharp & Dohme LLC | $13.83 | 2021 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $13.15 | 2023 | Cycloset |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Janna Chun listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.